CQDM

Consortium sur la découverte du médicament Navigation
  • HOME
  • ABOUT
    • MISSION, VISION AND IMPACT
    • STRUCTURE AND GOVERNANCE
    • TEAM
    • MEMBERS
    • COLLABORATORS
    • REPORTS
    • 10th ANNIVERSARY
  • PROGRAMS
    • QUANTUM LEAP
    • SYNERGIQC
    • MENTORSHIP
    • COMPLETED PROGRAMS
  • FUNDED PROJECTS
  • NEWS
  • CONTACT
  • FR
  • SPECIAL INITIATIVES
    • FACS
    • CATALIS
  • HOME
  • ABOUT
    • MISSION, VISION AND IMPACT
    • STRUCTURE AND GOVERNANCE
    • TEAM
    • MEMBERS
    • COLLABORATORS
    • REPORTS
    • 10th ANNIVERSARY
  • PROGRAMS
    • QUANTUM LEAP
    • SYNERGIQC
    • MENTORSHIP
    • COMPLETED PROGRAMS
  • FUNDED PROJECTS
  • NEWS
  • CONTACT
  • FR
  • SPECIAL INITIATIVES
    • FACS
    • CATALIS

Post Archive by Year

Announcement of an investment of close to $8 million dollars in biopharmaceutical research in Québec

Monday June 8th, 2009News & Events

Announcement of a new funding from the Government of Canada

Monday February 23rd, 2009News & Events

LATEST NEWS

  • Amgen and Takeda join the Quantum Leap project led by CQDM and Feldan Therapeutics
    Tuesday June 4th, 2019
    Amgen and Takeda join the Quantum Leap project led by […]
  • Contribution from the MEI ($3.3M) allows CQDM to support 5 biopharmaceutical research projects ($15.5M)
    Tuesday June 4th, 2019
    These highly innovative technologies will address […]
  • The CCS, CQDM and biotech companies will invest nearly $10M to support 3 breast cancer research projects
    Saturday June 1st, 2019
    Montreal, June 1, 2019 – The Canadian Cancer […]

About CQDM

  • Our Mission, Vision and Impact
  • Structure & Governance
  • Team
  • Members
  • Collaborators
  • Contact Us

Programs

  • SynergiQC
  • Quantum Leap
  • Mentorship
  • Completed Programs

Follow Us!

Tweets by @CQDM_Canada

© CQDM 2019 // Web: Draxo Marketing

We use cookies and other tracking technologies to improve your browsing experience on our website. By browsing our website, you consent to our use of cookies and other tracking technologies. Accept